Large-scale testing (Phase 3)Ended earlyNCT00447187
What this trial is testing
Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk
Who this might be right for
Corneal DiseasesCornea Transplant
Lux Biosciences, Inc. 368